Daniel Allen

Insider Reports History

Entity
Individual
Location
299 Park Avenue South, Suite 90959, New York, NY
Signature
/s/ Daniel Allen
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel Allen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PharmaCyte Biotech, Inc. Director Stock Option (Right to Buy) 125K Dec 28, 2022 Direct

Insider Reports Filed by Daniel Allen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PMCB PharmaCyte Biotech, Inc. Dec 28, 2022 1 $0 4 Dec 30, 2022 Director
PMCB PharmaCyte Biotech, Inc. Aug 15, 2022 0 $0 3 Aug 24, 2022 Director